After finishing at $6.72 in the prior trading day, Surgepays Inc (NASDAQ: SURG) closed at $6.30, down -6.25%. In other words, the price has decreased by -$0.42 from its previous closing price. On the day, 1362527 shares were traded. SURG stock price reached its highest trading level at $6.67 during the session, while it also had its lowest trading level at $5.92.
Ratios:
Our goal is to gain a better understanding of SURG by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 8.58 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 8.61. For the most recent quarter (mrq), Quick Ratio is recorded 1.57 and its Current Ratio is at 2.57. In the meantime, Its Debt-to-Equity ratio is 0.23 whereas as Long-Term Debt/Eq ratio is at 0.21.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 15 ’23 when Cox Kevin Brian bought 5,200 shares for $4.72 per share. The transaction valued at 24,544 led to the insider holds 4,507,894 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SURG now has a Market Capitalization of 106.86M and an Enterprise Value of 99.65M. As of this moment, Surgepays’s Price-to-Earnings (P/E) ratio for their current fiscal year is 4.46, and their Forward P/E ratio for the next fiscal year is 3.59. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.77 while its Price-to-Book (P/B) ratio in mrq is 3.81. Its current Enterprise Value per Revenue stands at 0.71 whereas that against EBITDA is 4.33.
Stock Price History:
Over the past 52 weeks, SURG has reached a high of $9.23, while it has fallen to a 52-week low of $3.88. The 50-Day Moving Average of the stock is 7.23, while the 200-Day Moving Average is calculated to be 6.02.
Shares Statistics:
The stock has traded on average 678.16K shares per day over the past 3-months and 796.49k shares per day over the last 10 days, according to various share statistics. A total of 14.12M shares are outstanding, with a floating share count of 11.51M. Insiders hold about 33.66% of the company’s shares, while institutions hold 7.84% stake in the company. Shares short for SURG as of Feb 15, 2024 were 1.98M with a Short Ratio of 2.92, compared to 2.16M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 11.69% and a Short% of Float of 17.55%.
Earnings Estimates
Its stock is currently analyzed by 3 different market analysts. On average, analysts expect EPS of $0.41 for the current quarter, with a high estimate of $0.51 and a low estimate of $0.28, while EPS last year was $0.25. The consensus estimate for the next quarter is $0.45, with high estimates of $0.54 and low estimates of $0.36.
Analysts are recommending an EPS of between $1.71 and $1.46 for the fiscal current year, implying an average EPS of $1.6. EPS for the following year is $1.75, with 3 analysts recommending between $2.29 and $1.44.
Revenue Estimates
3 analysts predict $33.52M in revenue for the current quarter. It ranges from a high estimate of $35M to a low estimate of $32.08M. As of the current estimate, Surgepays Inc’s year-ago sales were $36.23M, an estimated decrease of -7.50% from the year-ago figure. For the next quarter, 2 analysts are estimating revenue of $34.91M, a decrease of -4.40% over than the figure of -$7.50% in the same quarter last year. There is a high estimate of $35M for the next quarter, whereas the lowest estimate is $34.82M.
A total of 3 analysts have provided revenue estimates for SURG’s current fiscal year. The highest revenue estimate was $140M, while the lowest revenue estimate was $136.91M, resulting in an average revenue estimate of $138.4M. In the same quarter a year ago, actual revenue was $121.54M, up 13.90% from the average estimate. Based on 3 analysts’ estimates, the company’s revenue will be $145.89M in the next fiscal year. The high estimate is $148M and the low estimate is $141.83M. The average revenue growth estimate for next year is up 5.40% from the average revenue estimate for this year.
